BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37863961)

  • 1. Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer.
    Børretzen A; Reisæter LAR; Ringheim A; Gravdal K; Haukaas SA; Fasmer KE; Haldorsen IHS; Beisland C; Akslen LA; Halvorsen OJ
    Sci Rep; 2023 Oct; 13(1):17949. PubMed ID: 37863961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
    Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
    Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatitis, the Great Mimicker of Prostate Cancer: Can We Differentiate Them Quantitatively With Multiparametric MRI?
    Uysal A; Karaosmanoğlu AD; Karcaaltıncaba M; Akata D; Akdogan B; Baydar DE; Ozmen MN
    AJR Am J Roentgenol; 2020 Nov; 215(5):1104-1112. PubMed ID: 32901562
    [No Abstract]   [Full Text] [Related]  

  • 4. Standard diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MRI of musculoskeletal tumours: correlations with Ki67 proliferation status.
    Zhan J; Hao D; Wang D; Yue B; Zhou R; Tian N; Liu M; Gao C; Xu W; Cui J
    Clin Radiol; 2021 Dec; 76(12):941.e11-941.e18. PubMed ID: 34579866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer.
    Li L; Wang K; Sun X; Wang K; Sun Y; Zhang G; Shen B
    Med Sci Monit; 2015 Feb; 21():376-82. PubMed ID: 25640082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
    Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
    AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voxel-wise correlation of positron emission tomography/computed tomography with multiparametric magnetic resonance imaging and histology of the prostate using a sophisticated registration framework.
    Reynolds HM; Williams S; Jackson P; Mitchell C; Hofman MS; Hicks RJ; Murphy DG; Haworth A
    BJU Int; 2019 Jun; 123(6):1020-1030. PubMed ID: 30536698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of quantitative parameters and radiomic features as inputs into machine learning models to predict the Gleason score of prostate cancer lesions.
    Nai YH; Cheong DLH; Roy S; Kok T; Stephenson MC; Schaefferkoetter J; Totman JJ; Conti M; Eriksson L; Robins EG; Wang Z; Chua WY; Ang BWL; Singha AK; Thamboo TP; Chiong E; Reilhac A
    Magn Reson Imaging; 2023 Jul; 100():64-72. PubMed ID: 36933775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of DISCO and MUSE-DWI combined with prostate specific antigen density in the diagnosis and risk stratification of prostate cancer].
    Chen ZQ; Zhang D; Wang Z; Song N; Ma AL; Zhang SR; Cai L
    Zhonghua Yi Xue Za Zhi; 2023 May; 103(19):1461-1468. PubMed ID: 37198108
    [No Abstract]   [Full Text] [Related]  

  • 10. Differentiation of bone metastases from prostate cancer and benign red marrow depositions of the pelvic bone with multiparametric MRI.
    Park S; Park JG; Jun S; Kim H; Kim TS; Kang H
    Magn Reson Imaging; 2020 Nov; 73():118-124. PubMed ID: 32860869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimising preoperative risk stratification tools for prostate cancer using mpMRI.
    Reisæter LAR; Fütterer JJ; Losnegård A; Nygård Y; Monssen J; Gravdal K; Halvorsen OJ; Akslen LA; Biermann M; Haukaas S; Rørvik J; Beisland C
    Eur Radiol; 2018 Mar; 28(3):1016-1026. PubMed ID: 28986636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of multiparametric MRI features to identify the presence of prevalent cribriform pattern in the peripheral zone tumors.
    Gaudiano C; Bianchi L; De Cinque A; Corcioni B; Giunchi F; Schiavina R; Fiorentino M; Brunocilla E; Golfieri R
    Radiol Med; 2022 Feb; 127(2):174-182. PubMed ID: 34850354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Prostate MRI Analysis Following Fluvastatin Therapy for Localized Prostate Cancer - A Pilot Study.
    Avery A; Sussman M; Longo J; Menezes RJ; Hamilton RJ; der Kwast THV; Fleshner NE; Penn LZ; Ghai S
    Can Assoc Radiol J; 2021 Nov; 72(4):750-758. PubMed ID: 33563030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application evaluation of DCE-MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer.
    Ma XZ; Lv K; Sheng JL; Yu YX; Pang PP; Xu MS; Wang SW
    Oncol Lett; 2019 Mar; 17(3):3077-3084. PubMed ID: 30867737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
    Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
    World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer.
    Gravdal K; Halvorsen OJ; Haukaas SA; Akslen LA
    Cancer Res; 2009 Jun; 69(11):4708-15. PubMed ID: 19487287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced MRI perfusion parameters are imaging biomarkers for angiogenesis in lung cancer.
    Du Y; Zhang S; Liang T; Shang J; Guo C; Lian J; Gong H; Yang J; Niu G
    Acta Radiol; 2023 Feb; 64(2):572-580. PubMed ID: 35369721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Findings in 1,123 Men with Preoperative
    Raveenthiran S; Yaxley WJ; Franklin T; Coughlin G; Roberts M; Gianduzzo T; Kua B; Samaratunga H; Delahunt B; Egevad L; Wong D; McEwan L; Brown N; Parkinson R; Esler R; Yaxley JW
    J Urol; 2022 Mar; 207(3):573-580. PubMed ID: 34694140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative contrast-enhanced perfusion kinetics in multiparametric MRI in differentiating prostate cancer from chronic prostatitis: results from a pilot study.
    Sureka B; Elhence P; Khera PS; Choudhary GR; Pandey H; Garg PK; Yadav K; Goel A
    Br J Radiol; 2019 Aug; 92(1100):20190181. PubMed ID: 31184934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active Surveillance.
    Salguero J; Gómez-Gómez E; Valero-Rosa J; Carrasco-Valiente J; Mesa J; Martin C; Campos-Hernández JP; Rubio JM; López D; Requena MJ
    Korean J Radiol; 2021 Apr; 22(4):559-567. PubMed ID: 33289358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.